Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2013 Jan 29:8:21.
doi: 10.1186/1748-717X-8-21.

Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century

Affiliations
Multicenter Study

Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century

Adam S Garden et al. Radiat Oncol. .

Abstract

Background: We performed this study to assess outcomes of patients with oropharyngeal cancer treated with modern therapy approaches.

Methods: Demographics, treatments and outcomes of patients diagnosed with Stage 3- 4B squamous carcinoma of the oropharynx, between 2000-2007 were tabulated and analyzed.

Results: The cohort consisted of 1046 patients. The 5-year actuarial overall survival, recurrence-free survival and local-regional control rates for the entire cohort were 78%, 77% and 87% respectively. More advanced disease, increasing T-stage and smoking were associated with higher rates of local-regional recurrence and poorer survival.

Conclusions: Patients with locally advanced oropharyngeal cancer have a relatively high survival rate. Patients' demographics and primary tumor volume were very influential on these favorable outcomes. In particular, patients with small primary tumors did very well even when treatment was not intensified with the addition of chemotherapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Number of patients treated with conventional radiation techniques and intensity-modulated radiation (IMRT).
Figure 2
Figure 2
Local-regional control rates stratified by smoking. a) stratification by status; b) stratification by pack-year history.
Figure 3
Figure 3
Local-regional control rates stratified by T-category.
Figure 4
Figure 4
Local-regional control rates stratified by use of concurrent chemotherapy (CTX) with radiation and T-category. T1-2, no CTX, n = 470; T1-2, CTX, n = 170; T3-4 no CTX, n = 63; T3-4 CTX, n=343.

References

    1. Bourhis J, Overgaard J, Audry H. et al.Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet. 2006;368:843–854. doi: 10.1016/S0140-6736(06)69121-6. - DOI - PubMed
    1. Fu KK, Pajak TF, Trotti A. et al.A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000;48:7–16. doi: 10.1016/S0360-3016(00)00663-5. - DOI - PubMed
    1. Overgaard J, Hansen H, Specht L. et al.Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet. 2003;362:933–940. doi: 10.1016/S0140-6736(03)14361-9. - DOI - PubMed
    1. Pignon JP, le Maitre A, Maillard E, Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009;92:4–14. doi: 10.1016/j.radonc.2009.04.014. - DOI - PubMed
    1. Posner MR, Hershock DM, Blajman CR. et al.Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007;357:1705–1715. doi: 10.1056/NEJMoa070956. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources